Abstract | BACKGROUND/AIM: B cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is up-regulated in several cancers; therefore, we investigated the effects of BMI1 inhibitors on leukemia cells. MATERIALS AND METHODS: RESULTS:
PTC-209 and PRT4165 suppressed the growth of all cell lines through apoptosis.Artemisinin acted only on Jurkat cells. BMI1 inhibitors and BMI1-specific siRNA down-regulated the expression of NOTCH signaling proteins NOTCH1, HES1, and MYC. All but one cell lines did not have the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene targeted by BMI1, thus the inhibitors acted through CDKN2A-independent pathways. CONCLUSION: BMI1 inhibition suppressed proliferation of leukemia cells through NOTCH signaling which functions downstream of BMI1, suggesting that BMI1 inhibitors can be candidate targeted drugs against leukemia.
|
Authors | Mika Ohtaka, Mai Itoh, Shuji Tohda |
Journal | Anticancer research
(Anticancer Res)
Vol. 37
Issue 11
Pg. 6047-6053
(11 2017)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 29061784
(Publication Type: Journal Article)
|
Copyright | Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Chemical References |
- BMI1 protein, human
- Heterocyclic Compounds, 2-Ring
- PTC-209
- RNA, Small Interfering
- Receptors, Notch
- Thiazoles
- Polycomb Repressive Complex 1
|
Topics |
- Apoptosis
(drug effects)
- Cell Proliferation
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Heterocyclic Compounds, 2-Ring
(pharmacology)
- Humans
- Leukemia, Myeloid, Acute
(drug therapy, metabolism, pathology)
- Leukemia, T-Cell
(drug therapy, metabolism, pathology)
- Polycomb Repressive Complex 1
(antagonists & inhibitors, genetics, metabolism)
- RNA, Small Interfering
(genetics)
- Receptors, Notch
(antagonists & inhibitors, genetics, metabolism)
- Signal Transduction
(drug effects)
- Thiazoles
(pharmacology)
- Tumor Cells, Cultured
|